The Union for International Cancer Control and its partners, including a number of pharmaceutical companies, industry bodies and the Medicines Patent Pool, say that the new Access to Oncology Medicines Coalition (ATOM) will help lower-income countries develop the ability to offer access to essential cancer drugs and to monitor their supply.
Global Cancer Coalition Seeks To Boost Access To Medicines In Lower-Income Countries
The Union for International Cancer Control and its industry and other partners say the Access to Oncology Medicines Coalition will help to facilitate access to cancer drugs in low- and lower-middle-income countries.
More from Market Access
More from Pink Sheet
• By
While the pharma industry appears to be exempt from US tariffs imposed by President Trump, a member of the UK House of Lords says the details are unknown and warned that uncertainty “leads to less investment” in business as a whole.
• By
The EU Clinical Trials Information System has achieved primary registry designation in the International Clinical Trials Registry Platform in a move that is expected to reduce regulatory burden for companies and help them lower compliance costs by aligning with publication requirements in medical journals.
• By
The UK government has listened to industry concerns about high clawback rates under the voluntary scheme and will review it in June in a bid to resolve the issue and “move on to bigger and more important things,” health secretary Wes Streeting says.